Header cover image

U.K. (FTSE) Biotech Industry Analysis

UpdatedMar 19, 2024
DataAggregated Company Financials
Companies28
  • 7D-2.4%
  • 3M-9.6%
  • 1Y-29.7%
  • YTD-12.9%

Over the last 7 days, the Biotech industry has dropped 1.9%, driven by a pullback from Genus of 3.8%. Meanwhile, Faron Pharmaceuticals Oy actually outperformed within the industry, gaining 30% in the last week. The industry has fallen 29% in the last year. As for the next few years, earnings are expected to grow by 19% per annum.

Industry Valuation and Performance

Has the U.K. Biotech Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 19 Mar 2024UK£3.0bUK£897.7m-UK£203,616,909.2533.3x-14.9x3.4x
Thu, 15 Feb 2024UK£3.3bUK£913.5m-UK£198,242,013.3531x-16.8x3.6x
Sat, 13 Jan 2024UK£6.3bUK£1.3b-UK£245,123,674.0037.6x-25.9x5x
Mon, 11 Dec 2023UK£6.2bUK£1.3b-UK£245,939,365.0036.9x-25.1x4.9x
Wed, 08 Nov 2023UK£6.4bUK£1.3b-UK£243,321,128.0038.5x-26.2x5x
Fri, 06 Oct 2023UK£6.4bUK£1.3b-UK£251,229,291.0038.4x-25.7x5x
Sun, 03 Sep 2023UK£6.7bUK£1.3b-UK£205,920,114.0023.6x-32.4x5.3x
Tue, 01 Aug 2023UK£6.9bUK£1.3b-UK£208,653,840.0023.6x-33.1x5.5x
Thu, 29 Jun 2023UK£6.7bUK£1.3b-UK£209,044,141.0023.9x-32x5.3x
Sat, 27 May 2023UK£7.0bUK£1.3b-UK£205,119,176.0023.3x-34x5.5x
Mon, 24 Apr 2023UK£7.2bUK£1.2b-UK£156,309,305.0023.5x-46x5.8x
Wed, 22 Mar 2023UK£7.2bUK£1.2b-UK£155,795,009.0025.3x-46.1x5.8x
Fri, 17 Feb 2023UK£7.4bUK£1.2b-UK£150,075,119.0028.1x-49.4x6.3x
Sun, 15 Jan 2023UK£7.7bUK£1.2b-UK£140,681,116.0028.5x-54.7x6.6x
Tue, 13 Dec 2022UK£7.2bUK£1.2b-UK£136,959,345.0025x-52.5x6.2x
Thu, 10 Nov 2022UK£7.8bUK£1.2b-UK£141,258,899.0023.4x-55.2x6.7x
Sat, 08 Oct 2022UK£7.2bUK£1.2b-UK£149,697,721.0026.4x-48.4x6.2x
Mon, 05 Sep 2022UK£7.0bUK£1.1b-UK£146,610,750.0034.3x-48x6.3x
Wed, 03 Aug 2022UK£7.3bUK£1.1b-UK£199,929,586.0037.7x-36.4x6.5x
Fri, 01 Jul 2022UK£6.8bUK£1.1b-UK£167,287,250.0035.7x-40.8x6.1x
Sun, 29 May 2022UK£7.2bUK£1.1b-UK£146,482,002.0038.9x-49.1x6.5x
Tue, 26 Apr 2022UK£7.2bUK£1.1b-UK£91,865,999.0037.5x-78.6x6.6x
Thu, 24 Mar 2022UK£7.3bUK£1.1b-UK£77,066,195.0042.7x-95.3x6.7x
Sat, 19 Feb 2022UK£8.2bUK£1.1b-UK£119,739,479.0034.4x-68.3x7.5x
Mon, 17 Jan 2022UK£9.7bUK£1.1b-UK£123,388,341.0047.3x-78.3x8.9x
Wed, 15 Dec 2021UK£10.9bUK£1.1b-UK£121,130,360.0049.3x-89.7x10x
Fri, 12 Nov 2021UK£12.0bUK£1.1b-UK£149,906,152.0070.1x-79.8x11x
Sun, 10 Oct 2021UK£11.8bUK£1.1b-UK£148,479,118.0068.8x-79.6x10.7x
Tue, 07 Sep 2021UK£12.8bUK£1.1b-UK£143,503,184.6256.3x-89.3x12.2x
Thu, 05 Aug 2021UK£12.0bUK£1.0b-UK£172,541,949.9129.9x-69.5x11.7x
Sun, 09 May 2021UK£11.5bUK£1.0b-UK£166,311,048.5230.3x-69.3x11.4x
Price to Earnings Ratio

-65x


Total Market Cap: UK£10.8bTotal Earnings: -UK£166,311,048.52Total Revenue: UK£1.0bTotal Market Cap vs Earnings and Revenue0%0%0%
U.K. Biotech Industry Price to Earnings3Y Average -55.4x202220232024
Current Industry PE
  • Investors are pessimistic on the British Biotechs industry, indicating that they anticipate long term growth rates will be lower than they have historically.
  • The 3-year average PS ratio of 7.8x is higher than the industry's current PS ratio of 3.4x.
Past Earnings Growth
  • The earnings for companies in the Biotechs industry have deteriorated over the last three years.
  • Revenues have also declined 4.0% per year.
  • This means overall sales from these companies are declining and losses are subsequently expanding as well.

Industry Trends

Which industries have driven the changes within the U.K. Healthcare industry?

GB Market0.54%
Healthcare-1.35%
Biotech-2.45%
Biotech-2.45%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
FARN Faron Pharmaceuticals OyUK£1.7529.6%
+UK£27.5m
-44.4%PE-4.6x
PRTC PureTech HealthUK£2.044.0%
+UK£21.1m
0.5%PS59.8x
AREC Arecor TherapeuticsUK£1.4811.3%
+UK£4.6m
-43.3%PS13.4x
4BB 4basebioUK£9.753.2%
+UK£3.8m
43.4%PS352.7x
ETX e-therapeuticsUK£0.132.0%
+UK£1.5m
-6.4%PS221.3x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SCLP

UK£0.10

Scancell Holdings

7D

-1.2%

1Y

-36.9%

FARN

UK£1.75

Faron Pharmaceuticals Oy

7D

29.6%

1Y

-44.4%

OXB

UK£1.90

Oxford Biomedica

7D

-9.5%

1Y

-57.3%

AVCT

UK£0.51

Avacta Group

7D

-10.7%

1Y

-57.7%

ONC

UK£0.18

Oncimmune Holdings

7D

-7.7%

1Y

-50.3%

TRX

UK£0.69

Tissue Regenix Group

7D

2.9%

1Y

13.2%

VRCI

UK£0.098

Verici Dx

7D

-4.9%

1Y

105.3%

ETX

UK£0.13

e-therapeutics

7D

2.0%

1Y

-6.4%

DEST

UK£0.34

Destiny Pharma

7D

3.0%

1Y

8.8%

4BB

UK£9.75

4basebio

7D

3.2%

1Y

43.4%

BVXP

UK£46.00

Bioventix

7D

-3.2%

1Y

24.3%

PRTC

UK£2.04

PureTech Health

7D

4.0%

1Y

0.5%

OPTI

UK£0.25

OptiBiotix Health

7D

1.0%

1Y

124.4%

NIOX

UK£0.64

NIOX Group

7D

-4.5%

1Y

39.1%